Date of Report (Date of Earliest Event Reported): | November 4, 2024 |
Ohio | 000-20557 | 34-1562374 | ||||||||||||
(State of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
Title of each class: | Trading Symbol | Name of each exchange on which registered: | ||||||||||||
Common stock, $0.00 par value, $0.01 stated value | ANDE | The NASDAQ Stock Market LLC |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Inline XBRL for the cover page of this Current Report on Form 8-K |
The Andersons, Inc. | |||||||||||
November 4, 2024 | By: | /s/ Brian A. Valentine | |||||||||
Brian A. Valentine | |||||||||||
Executive Vice President and Chief Financial Officer |
$ in millions, except per share amounts | ||||||||||||||||||||
Q3 2024 | Q3 2023 | Variance | YTD 2024 |
YTD 2023 |
Variance | |||||||||||||||
Pretax Income | $ | 62.2 | $ | 38.4 | $ | 23.8 | $ | 133.5 | $ | 77.8 | $ | 55.7 | ||||||||
Pretax Income Attributable to the Company1 |
38.1 | 17.6 | 20.5 | 85.8 | 73.7 | 12.1 | ||||||||||||||
Adjusted Pretax Income
Attributable to the Company1
|
34.6 | 10.1 | 24.5 | 86.1 | 90.7 | (4.6) | ||||||||||||||
Trade1 |
22.7 | 5.4 | 17.3 | 41.0 | 36.3 | 4.7 | ||||||||||||||
Renewables1 |
28.5 | 26.3 | 2.2 | 63.8 | 65.0 | (1.2) | ||||||||||||||
Nutrient & Industrial | (6.1) | (8.5) | 2.4 | 15.4 | 23.7 | (8.3) | ||||||||||||||
Other1 |
(10.5) | (13.1) | 2.6 | (34.1) | (34.3) | 0.2 | ||||||||||||||
Net Income Attributable to the Company |
27.4 | 9.7 | 17.7 | 68.9 | 50.0 | 18.9 | ||||||||||||||
Adjusted Net Income Attributable to the Company1 |
24.7 | 4.6 | 20.1 | 69.8 | 63.7 | 6.1 | ||||||||||||||
Diluted Earnings Per Share ("EPS") | 0.80 | 0.28 | 0.52 | 2.01 | 1.46 | 0.55 | ||||||||||||||
Adjusted EPS1 |
0.72 | 0.13 | 0.59 | 2.04 | 1.86 | 0.18 | ||||||||||||||
EBITDA1 |
101.0 | 77.8 | 23.2 | 246.6 | 210.4 | 36.2 | ||||||||||||||
Adjusted EBITDA from Continuing Operations1 |
$ | 97.4 | $ | 70.3 | $ | 27.1 | $ | 246.9 | $ | 270.0 | $ | (23.1) | ||||||||
1 Non-GAAP financial measures; see appendix for explanations and reconciliations. |
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
(in thousands, except per share data) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Sales and merchandising revenues | $ | 2,620,988 | $ | 3,635,691 | $ | 8,134,410 | $ | 11,537,112 | |||||||||||||||
Cost of sales and merchandising revenues | 2,443,863 | 3,477,990 | 7,653,594 | 11,009,463 | |||||||||||||||||||
Gross profit | 177,125 | 157,701 | 480,816 | 527,649 | |||||||||||||||||||
Operating, administrative and general expenses | 120,494 | 126,306 | 356,466 | 359,548 | |||||||||||||||||||
Asset impairment | — | — | — | 87,156 | |||||||||||||||||||
Interest expense, net | 8,361 | 8,188 | 21,494 | 38,766 | |||||||||||||||||||
Other income, net | 13,922 | 15,178 | 30,651 | 35,623 | |||||||||||||||||||
Income before income taxes | 62,192 | 38,385 | 133,507 | 77,802 | |||||||||||||||||||
Income tax provision | 10,731 | 7,862 | 16,911 | 23,710 | |||||||||||||||||||
Net income | 51,461 | 30,523 | 116,596 | 54,092 | |||||||||||||||||||
Net income attributable to noncontrolling interests | 24,096 | 20,815 | 47,674 | 4,088 | |||||||||||||||||||
Net income attributable to The Andersons, Inc. | $ | 27,365 | $ | 9,708 | $ | 68,922 | $ | 50,004 | |||||||||||||||
Earnings per share attributable to The Andersons, Inc. common shareholders: |
|||||||||||||||||||||||
Basic earnings: | $ | 0.80 | $ | 0.29 | $ | 2.03 | $ | 1.48 | |||||||||||||||
Diluted earnings: | $ | 0.80 | $ | 0.28 | $ | 2.01 | $ | 1.46 | |||||||||||||||
(in thousands) | September 30, 2024 | December 31, 2023 | September 30, 2023 | ||||||||||||||
Assets | |||||||||||||||||
Current assets: | |||||||||||||||||
Cash and cash equivalents | $ | 454,065 | $ | 643,854 | $ | 418,055 | |||||||||||
Accounts receivable, net | 756,618 | 762,549 | 816,686 | ||||||||||||||
Inventories | 884,339 | 1,166,700 | 985,292 | ||||||||||||||
Commodity derivative assets – current | 122,326 | 178,083 | 239,595 | ||||||||||||||
Other current assets | 113,726 | 55,777 | 67,471 | ||||||||||||||
Total current assets | 2,331,074 | 2,806,963 | 2,527,099 | ||||||||||||||
Property, plant and equipment, net | 709,951 | 693,365 | 680,188 | ||||||||||||||
Other assets, net | 347,274 | 354,679 | 380,815 | ||||||||||||||
Total assets | $ | 3,388,299 | $ | 3,855,007 | $ | 3,588,102 | |||||||||||
Liabilities and equity | |||||||||||||||||
Current liabilities: | |||||||||||||||||
Short-term debt | $ | 14,716 | $ | 43,106 | $ | 14,138 | |||||||||||
Trade and other payables | 774,347 | 1,055,473 | 822,153 | ||||||||||||||
Customer prepayments and deferred revenue | 67,899 | 187,054 | 211,867 | ||||||||||||||
Commodity derivative liabilities – current | 85,640 | 90,849 | 142,511 | ||||||||||||||
Current maturities of long-term debt | 27,727 | 27,561 | 27,535 | ||||||||||||||
Accrued expenses and other current liabilities | 207,543 | 232,288 | 189,430 | ||||||||||||||
Total current liabilities | 1,177,872 | 1,636,331 | 1,407,634 | ||||||||||||||
Long-term debt, less current maturities | 542,564 | 562,960 | 569,730 | ||||||||||||||
Other long-term liabilities | 144,855 | 139,329 | 161,652 | ||||||||||||||
Total liabilities | 1,865,291 | 2,338,620 | 2,139,016 | ||||||||||||||
Total equity | 1,523,008 | 1,516,387 | 1,449,086 | ||||||||||||||
Total liabilities and equity | $ | 3,388,299 | $ | 3,855,007 | $ | 3,588,102 |
Nine months ended September 30, | |||||||||||
(in thousands) | 2024 | 2023 | |||||||||
Operating Activities | |||||||||||
Net income | $ | 116,596 | $ | 54,092 | |||||||
Adjustments to reconcile net income to cash provided by operating activities: | |||||||||||
Depreciation and amortization | 91,626 | 93,800 | |||||||||
Asset impairment | — | 87,156 | |||||||||
Other | 15,146 | 1,347 | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | 3,498 | 406,263 | |||||||||
Inventories | 278,947 | 748,118 | |||||||||
Commodity derivatives | 49,327 | 99,479 | |||||||||
Other current and non-current assets | (59,376) | 2,048 | |||||||||
Payables and other current and non-current liabilities | (433,069) | (796,216) | |||||||||
Net cash provided by operating activities | 62,695 | 696,087 | |||||||||
Investing Activities | |||||||||||
Purchases of property, plant and equipment and capitalized software | (93,230) | (108,718) | |||||||||
Acquisition of businesses, net of cash acquired | (9,561) | (24,385) | |||||||||
Insurance proceeds | 9,219 | — | |||||||||
Proceeds from sale of a business | — | 10,318 | |||||||||
Other | 2,980 | 5,522 | |||||||||
Net cash used in investing activities | (90,592) | (117,263) | |||||||||
Financing Activities | |||||||||||
Net payments under short-term lines of credit | (27,054) | (261,152) | |||||||||
Payments of long-term debt | (20,649) | (42,734) | |||||||||
Distributions to noncontrolling interest owner | (87,325) | (44,304) | |||||||||
Dividends paid | (19,466) | (18,771) | |||||||||
Value of shares withheld for taxes | (8,101) | (6,627) | |||||||||
Proceeds from issuance of long-term debt | — | 100,000 | |||||||||
Other | — | (2,258) | |||||||||
Net cash used in financing activities | (162,595) | (275,846) | |||||||||
Effect of exchange rates on cash and cash equivalents | 703 | (192) | |||||||||
(Decrease) increase in cash and cash equivalents | (189,789) | 302,786 | |||||||||
Cash and cash equivalents at beginning of period | 643,854 | 115,269 | |||||||||
Cash and cash equivalents at end of period | $ | 454,065 | $ | 418,055 |
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
(in thousands, except per share data) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Net income | $ | 51,461 | $ | 30,523 | $ | 116,596 | $ | 54,092 | |||||||||||||||
Net income attributable to noncontrolling interests | 24,096 | 20,815 | 47,674 | 4,088 | |||||||||||||||||||
Net income attributable to The Andersons, Inc. | 27,365 | 9,708 | 68,922 | 50,004 | |||||||||||||||||||
Adjustments: | |||||||||||||||||||||||
Gain on sale of assets | — | (5,643) | — | (5,643) | |||||||||||||||||||
Gain on cost method investment | — | (4,798) | — | (4,798) | |||||||||||||||||||
Transaction related compensation | 1,668 | 1,999 | 8,568 | 4,606 | |||||||||||||||||||
Gain on deconsolidation of joint venture | — | — | (3,117) | (6,544) | |||||||||||||||||||
Insurance recoveries | (5,204) | — | (5,204) | (16,080) | |||||||||||||||||||
Asset impairment | — | 963 | — | 45,413 | |||||||||||||||||||
Income tax impact of adjustments1 |
884 | 2,367 | 632 | (3,255) | |||||||||||||||||||
Total adjusting items, net of tax | (2,652) | (5,112) | 879 | 13,699 | |||||||||||||||||||
Adjusted net income attributable to The Andersons, Inc. | $ | 24,713 | $ | 4,596 | $ | 69,801 | $ | 63,703 | |||||||||||||||
Diluted earnings per share attributable to The Andersons, Inc. common shareholders |
$ | 0.80 | $ | 0.28 | $ | 2.01 | $ | 1.46 | |||||||||||||||
Impact on diluted earnings (loss) per share | $ | (0.08) | $ | (0.15) | $ | 0.03 | $ | 0.40 | |||||||||||||||
Adjusted diluted earnings per share | $ | 0.72 | $ | 0.13 | $ | 2.04 | $ | 1.86 | |||||||||||||||
(in thousands) | Trade | Renewables | Nutrient & Industrial | Other | Total | ||||||||||||||||||||||||
Three months ended September 30, 2024 | |||||||||||||||||||||||||||||
Sales and merchandising revenues | $ | 1,747,715 | $ | 745,206 | $ | 128,067 | $ | — | $ | 2,620,988 | |||||||||||||||||||
Gross profit | 98,776 | 60,375 | 17,974 | — | 177,125 | ||||||||||||||||||||||||
Operating, administrative and general expenses |
75,825 | 8,839 | 24,591 | 11,239 | 120,494 | ||||||||||||||||||||||||
Other income, net | 8,720 | 1,760 | 3,323 | 119 | 13,922 | ||||||||||||||||||||||||
Income (loss) before income taxes | 26,266 | 52,583 | (6,132) | (10,525) | 62,192 | ||||||||||||||||||||||||
Income attributable to noncontrolling interests | — | 24,096 | — | — | 24,096 | ||||||||||||||||||||||||
Income (loss) before income taxes attributable to The Andersons, Inc.1 |
$ | 26,266 | $ | 28,487 | $ | (6,132) | $ | (10,525) | $ | 38,096 | |||||||||||||||||||
Adjustments to income (loss) before income taxes2 |
(3,536) | — | — | — | (3,536) | ||||||||||||||||||||||||
Adjusted income (loss) before income taxes attributable to The Andersons, Inc.1 |
$ | 22,730 | $ | 28,487 | $ | (6,132) | $ | (10,525) | $ | 34,560 | |||||||||||||||||||
Three months ended September 30, 2023 | |||||||||||||||||||||||||||||
Sales and merchandising revenues | $ | 2,639,059 | $ | 868,099 | $ | 128,533 | $ | — | $ | 3,635,691 | |||||||||||||||||||
Gross profit | 85,997 | 53,045 | 18,659 | — | 157,701 | ||||||||||||||||||||||||
Operating, administrative and general expenses | 79,247 | 8,332 | 26,233 | 12,494 | 126,306 | ||||||||||||||||||||||||
Other income, net | 7,838 | 3,346 | 606 | 3,388 | 15,178 | ||||||||||||||||||||||||
Income (loss) before income taxes | 8,073 | 47,096 | (8,452) | (8,332) | 38,385 | ||||||||||||||||||||||||
Income attributable to noncontrolling interests | — | 20,815 | — | — | 20,815 | ||||||||||||||||||||||||
Income (loss) before income taxes attributable to The Andersons, Inc.1 |
$ | 8,073 | $ | 26,281 | $ | (8,452) | $ | (8,332) | $ | 17,570 | |||||||||||||||||||
Adjustments to income (loss) before income taxes2 |
(2,681) | — | — | (4,798) | (7,479) | ||||||||||||||||||||||||
Adjusted income (loss) before income taxes attributable to The Andersons, Inc.1 |
$ | 5,392 | $ | 26,281 | $ | (8,452) | $ | (13,130) | $ | 10,091 | |||||||||||||||||||
1 Income (loss) before income taxes attributable to The Andersons, Inc. for each operating segment is defined as net sales and merchandising revenues plus identifiable other income less all identifiable operating expenses, including interest expense for carrying working capital and long-term assets and is reported net of the noncontrolling interest share of income.
2 Additional information on the individual adjustments that are included in the adjustments to income (loss) before income taxes can be found in the Reconciliation to EBITDA and Adjusted EBITDA table.
|
(in thousands) | Trade | Renewables | Nutrient & Industrial | Other | Total | ||||||||||||||||||||||||
Nine months ended September 30, 2024 | |||||||||||||||||||||||||||||
Sales and merchandising revenues | $ | 5,399,315 | $ | 2,088,372 | $ | 646,723 | $ | — | $ | 8,134,410 | |||||||||||||||||||
Gross profit | 256,706 | 133,672 | 90,438 | — | 480,816 | ||||||||||||||||||||||||
Operating, administrative and general expenses | 220,886 | 24,592 | 75,427 | 35,561 | 356,466 | ||||||||||||||||||||||||
Other income (loss), net | 18,287 | 7,686 | 4,880 | (202) | 30,651 | ||||||||||||||||||||||||
Income (loss) before income taxes | 37,615 | 114,574 | 15,437 | (34,119) | 133,507 | ||||||||||||||||||||||||
Income attributable to noncontrolling interests |
— | 47,674 | — | — | 47,674 | ||||||||||||||||||||||||
Income (loss) before income taxes attributable to The Andersons, Inc.1 |
$ | 37,615 | $ | 66,900 | $ | 15,437 | $ | (34,119) | $ | 85,833 | |||||||||||||||||||
Adjustments to income (loss) before income taxes2 |
3,364 | (3,117) | — | — | 247 | ||||||||||||||||||||||||
Adjusted income (loss) before income taxes attributable to The Andersons, Inc.1 |
$ | 40,979 | $ | 63,783 | $ | 15,437 | $ | (34,119) | $ | 86,080 | |||||||||||||||||||
Nine months ended September 30, 2023 | |||||||||||||||||||||||||||||
Sales and merchandising revenues | $ | 8,213,649 | $ | 2,585,396 | $ | 738,067 | $ | — | $ | 11,537,112 | |||||||||||||||||||
Gross profit | 283,886 | 137,140 | 106,623 | — | 527,649 | ||||||||||||||||||||||||
Operating, administrative and general expenses | 220,373 | 24,804 | 79,251 | 35,120 | 359,548 | ||||||||||||||||||||||||
Other income, net | 18,149 | 11,655 | 1,952 | 3,867 | 35,623 | ||||||||||||||||||||||||
Income (loss) before income taxes | 52,427 | 31,187 | 23,675 | (29,487) | 77,802 | ||||||||||||||||||||||||
Income attributable to noncontrolling interests | — | 4,088 | — | — | 4,088 | ||||||||||||||||||||||||
Income (loss) before income taxes attributable to The Andersons, Inc.1 |
$ | 52,427 | $ | 27,099 | $ | 23,675 | $ | (29,487) | $ | 73,714 | |||||||||||||||||||
Adjustments to income (loss) before income taxes2 |
(16,154) | 37,906 | — | (4,798) | 16,954 | ||||||||||||||||||||||||
Adjusted income (loss) before income taxes attributable to The Andersons, Inc.1 |
$ | 36,273 | $ | 65,005 | $ | 23,675 | $ | (34,285) | $ | 90,668 | |||||||||||||||||||
1 Income (loss) before income taxes attributable to The Andersons, Inc. for each operating segment is defined as net sales and merchandising revenues plus identifiable other income less all identifiable operating expenses, including interest expense for carrying working capital and long-term assets and is reported net of the noncontrolling interest share of income.
2 Additional information on the individual adjustments that are included in the adjustments to income (loss) before income taxes can be found in the Reconciliation to EBITDA and Adjusted EBITDA table. All adjustments are consistent with the EBITDA reconciliation with the exception of a $42.7 million difference in the Renewables segment which represents the asset impairment expense attributable to the non-controlling interest that is reflected in Income attributable to the noncontrolling interest within the reconciliation above.
|
(in thousands) | Trade | Renewables | Nutrient & Industrial | Other | Total | ||||||||||||||||||||||||
Three months ended September 30, 2024 | |||||||||||||||||||||||||||||
Net income (loss) | $ | 26,266 | $ | 52,583 | $ | (6,132) | $ | (21,256) | $ | 51,461 | |||||||||||||||||||
Interest expense (income) | 5,405 | 713 | 2,838 | (595) | 8,361 | ||||||||||||||||||||||||
Tax provision | — | — | — | 10,731 | 10,731 | ||||||||||||||||||||||||
Depreciation and amortization | 9,377 | 11,942 | 8,145 | 944 | 30,408 | ||||||||||||||||||||||||
EBITDA | 41,048 | 65,238 | 4,851 | (10,176) | 100,961 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA: | |||||||||||||||||||||||||||||
Transaction related compensation | 1,668 | — | — | — | 1,668 | ||||||||||||||||||||||||
Insurance recoveries | (5,204) | — | — | — | (5,204) | ||||||||||||||||||||||||
Total adjusting items | (3,536) | — | — | — | (3,536) | ||||||||||||||||||||||||
Adjusted EBITDA | $ | 37,512 | $ | 65,238 | $ | 4,851 | $ | (10,176) | $ | 97,425 | |||||||||||||||||||
Three months ended September 30, 2023 | |||||||||||||||||||||||||||||
Net income (loss) | $ | 8,073 | $ | 47,096 | $ | (8,452) | $ | (16,194) | $ | 30,523 | |||||||||||||||||||
Interest expense (income) | 6,515 | 963 | 1,484 | (774) | 8,188 | ||||||||||||||||||||||||
Tax provision | — | — | — | 7,862 | 7,862 | ||||||||||||||||||||||||
Depreciation and amortization | 9,331 | 12,328 | 7,464 | 2,092 | 31,215 | ||||||||||||||||||||||||
EBITDA | 23,919 | 60,387 | 496 | (7,014) | 77,788 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA: | |||||||||||||||||||||||||||||
Transaction related compensation | 1,999 | — | — | — | 1,999 | ||||||||||||||||||||||||
Gain on cost method investment | — | — | — | (4,798) | (4,798) | ||||||||||||||||||||||||
Gain on sale of assets | (5,643) | — | — | — | (5,643) | ||||||||||||||||||||||||
Gain on deconsolidation of joint venture | 963 | — | — | — | 963 | ||||||||||||||||||||||||
Total adjusting items | (2,681) | — | — | (4,798) | (7,479) | ||||||||||||||||||||||||
Adjusted EBITDA | $ | 21,238 | $ | 60,387 | $ | 496 | $ | (11,812) | $ | 70,309 |
(in thousands) | Trade | Renewables | Nutrient & Industrial | Other | Total | ||||||||||||||||||||||||
Nine months ended September 30, 2024 | |||||||||||||||||||||||||||||
Net income (loss) | $ | 37,615 | $ | 114,574 | $ | 15,437 | $ | (51,030) | $ | 116,596 | |||||||||||||||||||
Interest expense (income) | 16,492 | 2,192 | 4,454 | (1,644) | 21,494 | ||||||||||||||||||||||||
Tax provision | — | — | — | 16,911 | 16,911 | ||||||||||||||||||||||||
Depreciation and amortization | 27,946 | 35,626 | 23,903 | 4,151 | 91,626 | ||||||||||||||||||||||||
EBITDA | 82,053 | 152,392 | 43,794 | (31,612) | 246,627 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA: | |||||||||||||||||||||||||||||
Transaction related compensation | 8,568 | — | — | — | 8,568 | ||||||||||||||||||||||||
Insurance recoveries | (5,204) | — | — | — | (5,204) | ||||||||||||||||||||||||
Gain on deconsolidation of joint venture | — | (3,117) | — | — | (3,117) | ||||||||||||||||||||||||
Total adjusting items | 3,364 | (3,117) | — | — | 247 | ||||||||||||||||||||||||
Adjusted EBITDA | $ | 85,417 | $ | 149,275 | $ | 43,794 | $ | (31,612) | $ | 246,874 | |||||||||||||||||||
Nine months ended September 30, 2023 | |||||||||||||||||||||||||||||
Net income (loss) | $ | 52,427 | $ | 31,187 | $ | 23,675 | $ | (53,197) | $ | 54,092 | |||||||||||||||||||
Interest expense (income) | 29,235 | 5,648 | 5,649 | (1,766) | 38,766 | ||||||||||||||||||||||||
Tax provision | — | — | — | 23,710 | 23,710 | ||||||||||||||||||||||||
Depreciation and amortization | 26,659 | 39,224 | 21,518 | 6,399 | 93,800 | ||||||||||||||||||||||||
EBITDA | 108,321 | 76,059 | 50,842 | (24,854) | 210,368 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA: | |||||||||||||||||||||||||||||
Transaction related compensation | 4,606 | — | — | — | 4,606 | ||||||||||||||||||||||||
Insurance recoveries | (16,080) | — | — | — | (16,080) | ||||||||||||||||||||||||
Gain on sale of assets | (5,643) | — | — | — | (5,643) | ||||||||||||||||||||||||
Gain on deconsolidation of joint venture | — | (6,544) | — | — | (6,544) | ||||||||||||||||||||||||
Gain on cost method investment | — | — | — | (4,798) | (4,798) | ||||||||||||||||||||||||
Asset impairment | 963 | 87,156 | — | — | 88,119 | ||||||||||||||||||||||||
Total adjusting items | (16,154) | 80,612 | — | (4,798) | 59,660 | ||||||||||||||||||||||||
Adjusted EBITDA | $ | 92,167 | $ | 156,671 | $ | 50,842 | $ | (29,652) | $ | 270,028 |
Three Months Ended, | Twelve months ended September 30, 2024 |
||||||||||||||||||||||||||||
(in thousands) | December 31, 2023 | March 31, 2024 | June 30, 2024 | September 30, 2024 | |||||||||||||||||||||||||
Net income | $ | 78,437 | $ | 12,665 | $ | 52,470 | $ | 51,461 | $ | 195,033 | |||||||||||||||||||
Interest expense | 8,101 | 6,522 | 6,611 | 8,361 | 29,595 | ||||||||||||||||||||||||
Tax provision | 13,324 | 1,303 | 4,876 | 10,731 | 30,234 | ||||||||||||||||||||||||
Depreciation and amortization | 31,306 | 30,949 | 30,269 | 30,408 | 122,932 | ||||||||||||||||||||||||
EBITDA | 131,168 | 51,439 | 94,226 | 100,961 | 377,794 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA: | |||||||||||||||||||||||||||||
Transaction related compensation | 3,212 | 2,852 | 4,049 | 1,668 | 11,781 | ||||||||||||||||||||||||
Insurance recoveries | — | — | — | (5,204) | (5,204) | ||||||||||||||||||||||||
Gain on deconsolidation of joint venture | — | (3,117) | — | — | (3,117) | ||||||||||||||||||||||||
Goodwill impairment | 686 | — | — | — | 686 | ||||||||||||||||||||||||
Total adjusting items | 3,898 | (265) | 4,049 | (3,536) | 4,146 | ||||||||||||||||||||||||
Adjusted EBITDA | $ | 135,066 | $ | 51,174 | $ | 98,275 | $ | 97,425 | $ | 381,940 | |||||||||||||||||||
Three Months Ended, | Twelve months ended September 30, 2023 |
||||||||||||||||||||||||||||
December 31, 2022 | March 31, 2023 | June 30,2023 | September 30, 2023 | ||||||||||||||||||||||||||
Net income (loss) | $ | 21,170 | $ | (59,117) | $ | 82,686 | $ | 30,523 | $ | 75,262 | |||||||||||||||||||
Interest expense | 14,087 | 16,625 | 13,953 | 8,188 | 52,853 | ||||||||||||||||||||||||
Tax provision (benefit) | 9,933 | (5,884) | 21,732 | 7,862 | 33,643 | ||||||||||||||||||||||||
Depreciation and amortization | 33,476 | 32,220 | 30,365 | 31,215 | 127,276 | ||||||||||||||||||||||||
EBITDA | 78,666 | (16,156) | 148,736 | 77,788 | 289,034 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA: | |||||||||||||||||||||||||||||
Insured inventory expenses (recoveries) | 15,993 | (17,390) | 1,310 | — | (87) | ||||||||||||||||||||||||
Transaction related compensation | — | 1,668 | 939 | 1,999 | 4,606 | ||||||||||||||||||||||||
Gain on sale of assets | — | — | — | (5,643) | (5,643) | ||||||||||||||||||||||||
Gain on cost method investment | — | — | — | (4,798) | (4,798) | ||||||||||||||||||||||||
Asset impairment | 9,000 | 87,156 | — | 963 | 97,119 | ||||||||||||||||||||||||
Gain on deconsolidation of joint venture | — | — | (6,544) | — | (6,544) | ||||||||||||||||||||||||
Total adjusting items | 24,993 | 71,434 | (4,295) | (7,479) | 84,653 | ||||||||||||||||||||||||
Adjusted EBITDA | $ | 103,659 | $ | 55,278 | $ | 144,441 | $ | 70,309 | $ | 373,687 | |||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
(in thousands) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Cash (used in) provided by operating activities | $ | (2,112) | $ | 488,683 | $ | 62,695 | $ | 696,087 | |||||||||||||||
Changes in operating assets and liabilities | |||||||||||||||||||||||
Accounts receivable | (11,786) | 198,396 | 3,498 | 406,263 | |||||||||||||||||||
Inventories | (198,776) | 13,263 | 278,947 | 748,118 | |||||||||||||||||||
Commodity derivatives | 13,317 | (3,274) | 49,327 | 99,479 | |||||||||||||||||||
Other current and non-current assets | (8,789) | 3,295 | (59,376) | 2,048 | |||||||||||||||||||
Payables and other current and non-current liabilities | 117,728 | 214,870 | (433,069) | (796,216) | |||||||||||||||||||
Total changes in operating assets and liabilities | (88,306) | 426,550 | (160,673) | 459,692 | |||||||||||||||||||
Adjusting items impacting cash from operations before working capital changes: | |||||||||||||||||||||||
Less: Insured inventory recoveries | — | — | — | (16,080) | |||||||||||||||||||
Less: Unrealized foreign currency losses on receivables |
— | (12,088) | — | (12,088) | |||||||||||||||||||
Cash from operations before working capital changes | $ | 86,194 | $ | 50,045 | $ | 223,368 | $ | 208,227 |